WEGOVY FLEXTOUCH 1MG INJ

Composition

Semaglutide 1 mg/0.5 mL solution for injection (prefilled pen); 3 mL pen contains semaglutide 6 mg (delivers multiple 1 mg doses)

Uses of WEGOVY FLEXTOUCH 1MG INJ

Chronic weight management (obesity/overweight) as an adjunct to reduced-calorie diet and increased physical activity in eligible adults; may be used when weight-related comorbidities are present as per physician advice.

• •Helps significant weight loss when combined with diet and exercise
• •Reduces appetite and cravings
• •Improves metabolic parameters such as blood glucose control
• •Convenient once-weekly dosing
• •May reduce waist circumference and weight-related comorbidity risk

How it works

Semaglutide is a GLP-1 receptor agonist. It increases satiety, reduces hunger and energy intake, and slows gastric emptying, leading to weight loss. It also improves glucose regulation by enhancing glucose-dependent insulin secretion and lowering glucagon.

Directions for use

Subcutaneous injection only (abdomen, thigh, or upper arm) once weekly on the same day each week, with or without food. Rotate injection sites; do not inject intravenously or intramuscularly. Follow the dose-escalation schedule prescribed by the doctor; if a dose is missed, take within 5 days otherwise skip and take next scheduled dose.

Side effects

Common side effects of WEGOVY FLEXTOUCH 1MG INJ may include:

• •Nausea
• •